FADD and non-small cell lung carcinoma: Previous researches have proven that overexpression of FADD predicted unfavorable clinical outcomes in NSCLC (Bhojani et al., 2005; Chen et al., 2005; Chen et al., 2020), which was in line with the finding of this study.